Huw Nash
Directeur des opérations chez STOKE THERAPEUTICS, INC.
Profil
Dr. Huw M.
Nash is a Chief Operating & Business Officer at Stoke Therapeutics, Inc. Dr. Nash was previously employed as a Vice President-Corporate Development by Aileron Therapeutics, Inc. and a VP-External Collaborations & Founding Scientist by NeoGenesis Pharmaceuticals, Inc. He received his undergraduate degree from Harvard College and a doctorate degree from Harvard University.
Postes actifs de Huw Nash
| Sociétés | Poste | Début |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Directeur des opérations | 01/10/2017 |
Anciens postes connus de Huw Nash
| Sociétés | Poste | Fin |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Fondateur | 01/01/2013 |
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Corporate Officer/Principal | 01/01/2005 |
Formation de Huw Nash
| Harvard College | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| STOKE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |